Rare diseases
Investigational molecules
Locations
Back to Sweden1 clinical trial in Koping, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)SwedenThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on heart failure with preserved ejection fraction (HFpEF), exploring new therapeutic approaches for this challenging cardiovascular condition.
These studies aim to evaluate the effectiveness of standard treatments combined with specific medications to reduce hospitalizations and improve cardiovascular outcomes in patients with preserved ejection fraction heart failure.
Implementation of Registry-based Randomized Clinical Trials (RRCT) methodology to advance understanding of cardiovascular therapies and their real-world impact.
This research framework combines the rigor of randomized trials with the practical advantages of registry-based data collection to evaluate treatment effectiveness.
Investigation of medication combinations and their impact on cardiovascular health, focusing on reducing hospitalization rates and improving patient outcomes.
These trials examine how different therapeutic approaches can be optimized to better manage heart failure and reduce cardiovascular mortality.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
